Biocompatibility of the vital dye Acid Violet-17 on retinal pigment epithelial cells by Tura, Aysegül et al.
© 2016 Tura et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php 
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you 
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission 
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Clinical Ophthalmology 2016:10 1435–1445
Clinical Ophthalmology Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
1435
O r i g i n a l  r e s e a r C h
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/OPTH.S105695
Biocompatibility of the vital dye acid Violet-17 













1Department of Ophthalmology, 
University of schleswig-holstein, 
Lübeck, Germany; 2Department of 
Ophthalmology, ludwig-Maximilians 
University, Munich, Germany; 
3Department of Ophthalmology, 
Pallas Clinic, aarau, switzerland
Purpose: To examine the viability and differentiation of retinal pigment epithelial (RPE) cells 
after exposure to the vital dye Acid Violet-17 (AV-17).
Methods: Bovine RPE cells were incubated with AV-17 (0.0625–0.5 mg/mL) for 30 seconds 
or 5 minutes. Viability was determined by live/dead staining, cleaved CASP3 immunostainings, 
and MTT test. Actin cytoskeleton was visualized by Alexa 488-phalloidin. Immunocytochemistry 
was performed to determine the levels of ZO-1, CTNNB1, and KRT19. 
Results: Exposure to AV-17 at the concentrations of 0.25–0.5 mg/mL resulted in a dose-dependent 
decrease in viability, the loss of ZO-1 from tight junctions, translocation of CTNNB1 into the cyto-
plasm and nucleus, disarrangement of the actin cytoskeleton, and a slight increase in KRT19.
Conclusion: AV-17 at a concentration 0.125 mg/mL is likely to be well tolerated by the RPE 
cells, whereas the concentrations from 0.25 mg/mL onward can reduce viability and induce 
dedifferentiation particularly after long-term exposure.
Keywords: Acid Violet-17, retinal pigment epithelial cells, biocompatibility, viability, 
differentiation
Introduction
Vital dyes have significantly improved the success of vitreoretinal surgeries by enabling 
the visualization of preretinal tissues and membranes.1,2 Currently, the dyes such as 
Brilliant Blue G (BBG, Brilliant Peel), patent blue V (Blueron), indocyanine green 
(ICG), and trypan blue (TB) can be applied during pars plana vitrectomy for macular 
diseases, including macular holes, epiretinal membranes, and tractional (diabetic) 
macula. However, numerous studies have demonstrated adverse effects, such as toxic-
ity in the retina, alterations in the retinal pigment epithelial (RPE) cells, and a reduced 
visual acuity especially after the use of ICG or TB,3–6 resulting in an increasing concern 
regarding the clinical use of these dyes. Therefore, extensive safety testing of new 
candidate dyes should be performed before their application in humans.
Acid Violet-17 (AV-17/Coomassie violet R200) is a trityl dye, which exhibits similar 
chemical properties to BBG. To enhance the staining quality, AV-17 should be applied 
in a special solvent loaded with heavier water (D
2
O), which leads to a higher density. 
This dye could stain the anterior capsule of ex vivo porcine eyes and the internal limiting 
membrane (ILM) satisfactorily, without causing substantial histopathological altera-
tions in the retina.7 We have also recently reported that AV-17 was well tolerated at a 
concentration of up to 0.125 mg/mL in terms of retinal function, survival in the ganglion 
cell layer, and glial reactivity in isolated bovine retinas.8 However, the response of RPE 
cells is a further critical point, since these cells can also be exposed to the dye during 
macular hole surgery when the dye migrates through the macular hole into the subretinal 
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space.9,10 Indeed, several groups reported complications such 
as RPE atrophy and reduced visual acuity after macular hole 
surgery using the dyes TB11 and ICG.12
In a recent study, the viability of the human RPE cell 
line ARPE-19 after treatment with various dyes including 
AV-17 was evaluated, and a 3-minute exposure to AV-17 
was reported to be well tolerated at a maximal concentra-
tion of 0.05 mg/mL.13 Yet, in the case of RPE, the extent of 
cell differentiation is an equally critical parameter defining 
the safety of a dye. The RPE tissue comprises a monolayer 
of highly polarized and differentiated cells, with organelles 
and cytoskeletal elements localized to distinct subcellular 
positions.14–16 Formation of this differentiated architecture 
is promoted by the tight and cell–cell (adherens) junctions 
between adjacent cells. The tight and adherens junctions are 
further supported by linkage to the actin cytoskeleton via the 
linker proteins ZO-1 and CTNNB1, respectively. Accordingly, 
the loss of junctional integrity triggers the dedifferentiation 
of RPE cells, which would lead to a functional decline.16–18 
Studies on cultured human19 and bovine RPE cells20 demon-
strated that the exposure to ICG can alter the bioelectrical 
properties of these cells and induce premature senescence 
through oxidative stress. Likewise, the exposure of ARPE-19 
cells to ICG resulted in morphological alterations suggestive 
of cytoskeletal rearrangement and a decrease in viability.21
In this study, we explored the safety profile of AV-17 on 
differentiated RPE cultures by analyzing cell viability. We 
also evaluated the extent of differentiation with particular 
emphasis on the organization of the actin cytoskeleton and 
the integrity of tight and adherens junctions. Furthermore, 
the levels of KRT19, an intermediate filament associated 




Antibodies as well as the major chemicals and reagents 
used were listed in Table 1. The remaining chemicals were 
Table 1 Chemicals, reagents, and antibodies used
Chemicals and reagents
Item Company Catalog number
aV-17 Fluoron gmbh (neu-Ulm, germany) –
aV-17 solvent
(0.13 ml D2O, 1.9 mg na2hPO4, 0.3 mg 
nah2PO4, 8.2 mg naCl in 1 ml h2O)
Fluoron gmbh –
Phosphate buffered saline Life Technologies (Thermo Fisher Scientific, 
Waltham, Ma, Usa)
14190-169
Dulbecco’s Modified Eagle’s Medium/F-12 (1:1) Life Technologies (Thermo Fisher Scientific) 21331-046
Fetal bovine serum, heat-inactivated Life Technologies (Thermo Fisher Scientific) 10082-147
Glutamine/Penicillin/Streptomycin mixture Life Technologies (Thermo Fisher Scientific) 10378-016
0.05% Trypsin-0.02% eDTa Life Technologies (Thermo Fisher Scientific) 25300-054
Bsa, cell culture grade sigma-aldrich Co. (st louis, MO, Usa) a9418-100g
TgFbeta-2 Reliatech GmbH (Wolfenbüttel, Germany) 100-105
Phalloidin, alexa 488-conjugated Molecular Probes (Thermo Fisher Scientific) a12379
Primary antibodies
Antigen Type Clone Company Catalog number Dilution factor
CTnnB1 rabbit igg, 
monoclonal





e83-77 epitomics, Biomol 1476-1 1/100
KrT19 Mouse igg,
monoclonal
rCK108 Dako Denmark A/S, (Glostrup, Denmark) M088801-2 1/50
ZO-1 rabbit igg, 
polyclonal
– abcam (Cambridge, UK) ab59720 1/50
Secondary antibodies
Reactivity Type Label Company Catalog number Dilution factor
Mouse igg goat igg
(h+l)
alexa 546 Molecular Probes (Thermo Fisher Scientific) a-11003 1/100
rabbit igg goat igg
(h+l)
Cy3 Jackson ImmunoResearch Laboratories, Inc. 
(West grove, Pa, Usa)
111-165-003 1/200
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Biocompatibility of aV-17 on rPe cells
obtained from Sigma-Aldrich Co. (St Louis, MO, USA) or 
Carl Roth GmbH + Co. KG (Karlsruhe, Germany).
rPe culture
Bovine eyes were obtained from a local slaughterhouse and 
used within 5 hours post-mortem. RPE cells were isolated 
as described23,24 with slight modifications. Briefly, the eyes 
were submerged for 5 minutes in an 11% iodine solution 
(Betaisodona, Mundipharma GH, Limburg, Germany) 
followed by rinsing twice with phosphate buffered saline 
(PBS) for 5 minutes. Eyes were dissected circumferentially 
5 mm posterior to the limbus. Afterwards, the anterior seg-
ment, vitreous, and retina were discarded. The exposed retinal 
pigment epithelium was washed three times in PBS to remove 
the photoreceptor debris. The eyecup was filled with 0.05% 
trypsin–0.02% ethylenediaminetetraacetic acid solution and 
incubated for 75 minutes at 37°C. Dissociated RPE cells 
were collected using a Pasteur pipette avoiding injury to the 
Bruch’s membrane and pooled from 5 to 6 eyes. Cells were 
transferred into the culture medium (Dulbecco’s Modified 
Eagle’s Medium/F12 supplemented with 10% fetal bovine 
serum, 2 mM l-glutamine, 100 U/mL penicillin, 100 µg/mL 
streptomycin), centrifuged at 300 ×g for 8 minutes, and 
resuspended in fresh culture medium. Cells were seeded 
either into a 75 cm² culture flask or culture plates (six-well 
plate, 24-well fluorocarbon plate; Zell-Kontakt GmbH, 
Nörten-Hardenberg, Germany) and maintained in a humidi-
fied 37°C incubator with 5% CO
2
. After reaching confluence 
(1–2 weeks), cells in the flasks were subcultured further with 
trypsin–ethylenediaminetetraacetic acid treatment and seeded 
into six-, 24-, or 96-well plates. 
To achieve an in vitro setting that resembles the normal dif-
ferentiated cells in situ, we initially optimized the culture con-
ditions of RPE cells. For this purpose, confluent primary and 
subcultured RPE cells (passages 3–7) in the culture plates were 
maintained in a low- (2% v/v) serum medium for 8–16 weeks, 
with the replenishment of culture medium by one half every 
2–3 days. The extent of cellular junction formation and dif-
ferentiation was evaluated by performing immunofluorescence 
staining for ZO-1, CTNNB1, and KRT19 as described later, 
and the results are demonstrated in Figure 1. 
Treatment with aV-17
AV-17 was dissolved at concentrations between 0.0625 and 
0.5 mg/mL in the solvent, sterile filtered, and stored at 4°C 
until use. The culture medium was removed completely 
from the RPE cells grown in the six-, 24-, or 96-well plates, 
and the wells were filled immediately with the dye solution 
or solvent (100 µL/well in the 96-well plates, 250 µL/well 
in the 24-well plates, and 1 mL/well in the six-well plates). 
As control, a group of cells were treated with low-serum 
medium in the same manner. After incubation of 30 seconds 
or 5 minutes under ambient light, the solutions were dis-
carded, the cells were washed three times for 5 minutes in 
PBS at the aforementioned volumes, and allowed to recover 
in low-serum medium overnight at 37°C with 5% CO
2
 in dark. 
As additional controls, a group of cells treated with low-serum 
medium were incubated overnight in medium supplemented 
with 10 ng/mL TGFbeta-2 to stimulate dedifferentiation or 




 to induce cell injury.
Live/dead staining
Culture medium was aspirated gently, the cells were rinsed 
briefly with 0.1% glucose–PBS, and incubated for 15 minutes 
in 2 µM ethidium homodimer-1 and 2 µM calcein-AM 
(Molecular Probes, Thermo Fisher Scientific, Waltham, MA, 
USA) diluted in 0.1% glucose–PBS under protection from 
light. Cells were then fixed, permeabilized, counterstained 
with 4′,6-diamidino-2-phenylindole (DAPI) (1 µg/mL in 
PBS), mounted in Mowiol as previously described,25 and 
analyzed by fluorescence microscopy (Leica Microsystems, 
Wetzlar, Germany). Images of all the subgroups of a given 
experiment were acquired on the same day using a mono-
chrome digital camera (DFC 350 FX; Leica Microsystems) 
attached to the microscope and the Leica Application 
Software (Advanced Fluorescence 2.3.0, build 5131) under 
identical settings for exposure time, gain, and intensity. 
Quantification of the staining intensity was performed using 
the ImageJ software (National Institutes of Health, Bethesda, 
MD, USA, http://imagej.nih.gov/ij/, 1997–2014) on the 
images having an area of 0.04 mm2. The viability index was 
calculated from the ratio of the intensities of calcein and 
ethidium homodimer-1 stainings.
MTT test
Bovine RPE cells at passages 3–7 were seeded into the inner 
wells of 96-well culture plates at a density of 5,000 cells/
well, with six wells for each treatment group, and allowed to 
differentiate for 8–10 weeks. Cells were treated with the test 
substances and allowed to recover overnight as described. 
An additional group of cells were left untreated as normal 
controls. MTT test was performed on the following day as 
described.25 The absorbance values at 544 nm were read using 
a spectrophotometric plate reader (FLUOstar, BMG Labtech 
GmbH, Ortenberg, Germany). The background values of 
the negative control were subtracted from the absorbance 
values of all the test groups. For each test group, the aver-
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the corresponding six wells after background subtraction. 
Data are presented as the mean ± standard error of mean 
(SEM) of n=3 independent tests.
Immunofluorescence staining
Cells grown in 24-well fluorocarbon plates with excisable 
foil-bottoms (Zell-Kontakt GmbH, Nörten-Hardenberg, 
Germany) were fixed in 2% paraformaldehyde–PBS for 
10 minutes followed by 4% paraformaldehyde–PBS for 
10 minutes, rinsed three times in PBS, and incubated with 
the blocking buffer (3% BSA–PBS with 0.3% Triton X-100) 
for 30 minutes. Primary and secondary antibodies were 
diluted in the blocking buffer as indicated in Table 1. Cells 
were incubated with the primary antibodies overnight at 
4°C followed by secondary antibodies for 1 hour at room 
temperature protected from light. Actin filaments were 
stained with Alexa 488-phalloidin (240 units/mL in blocking 
buffer) for 30 minutes, and the nuclei were counterstained 
with DAPI (1 µg/mL in PBS) for 10 minutes, with the cells 
being washed three times in PBS after each step. The well 
bottom was excised using a scalpel and placed flatly onto a 
drop of PBS pipetted onto a microscope slide (25 µL/foil) 
with the cell-seeded side facing upward. Cells were mounted 
in Mowiol, stored at 4°C, and examined under a fluorescence 
Figure 1 Optimization of the culture conditions.
Notes: (A) Incubation of confluent primary RPE cells in a low-serum (2% v/v) medium for at least 8 weeks promoted cell differentiation as demonstrated by the expression 
of the tight junction protein ZO-1 and the adherens junction protein CTNNB1 at cell–cell boundaries. The actin cytoskeleton was also arranged circumferentially underneath 
the plasma membrane. (B) long-term incubation of subcultured rPe cells in low-serum medium also induced differentiation, as demonstrated by the translocation of 
CTNNB1 from the cytoplasm to underneath the plasma membrane, and the considerable decrease in the expression of KRT19 in contrast to the cells in high-serum (10% v/v) 
medium. scale bars =25 µm.
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Biocompatibility of aV-17 on rPe cells
microscope (Leica Microsystems). Images were acquired as 
described in the live/dead staining section.
Quantification of the staining intensity was performed 
using the ImageJ software on the images with an area of 
0.04 mm2 by marking all the cells that lie completely in the 
field of view. Intensity of junctional ZO-1 and CTNNB1 
was determined from the ratio of the intensity at the cell 
perimeter to the mean cytoplasmic intensity. To better iden-
tify the boundaries of cells that exhibit a very weak staining, 
the intensities of cleaved CASP3 and KRT19 stainings were 
quantified on the merged images, by using the DAPI and 
actin filament stainings, respectively, for cell identification 
and recording the green intensity values from the histograms 
of marked regions. The mean intensity of negative controls 
(incubated with the blocking buffer alone without the primary 
antibody) were subtracted from the intensity of test groups 
for all the immunostainings. 
statistical analysis
The data were analyzed by two-sided Student’s t-test 
assuming equal variance among the samples and the 
P-values 0.05 were considered as significant. Data are 
presented either as mean ± standard deviation (SD) of a 
representative set of experiments or mean ± SEM of n=3 
independent experiments.
Results
Viability of the primary and subcultured 
rPe cells in response to aV-17
Viability of the differentiated RPE cells after exposure 
to AV-17 was evaluated by the live/dead assay, extent of 
CASP3 cleavage, and the MTT test, which all reflect differ-
ent parameters. The live/dead assay employs the vital dye 
calcein, which emits green fluorescence after being processed 
by esterases in living cells and the red fluorescent nucleic 
acid dye ethidium homodimer-1, which cannot penetrate 
intact cell membranes. 
In the primary RPE cells, the 30-second exposure to the 
solvent or AV-17 (0.125 and 0.25 mg/mL) did not result in 
remarkable toxicity, as demonstrated by the strong cyto-
plasmic staining with calcein and the negligible ethidium 
homodimer-1 uptake. Though the cells exposed to 0.5 mg/mL 
AV-17 exhibited lower calcein staining, there was no sig-
nificant increase in the uptake of ethidium homodimer-1 
(Figure 2A). Following the 5-minute exposure, cells treated 
with the solvent or 0.125 mg/mL AV-17 also exhibited a 
high degree of viability. However, the cells exposed to 0.25 
and 0.5 mg/mL dye demonstrated lower levels of calcein 
staining or a gradual increase in the uptake of ethidium 
homodimer-1, resulting in a significant decrease of 36%–38% 
in the viability score calculated from the ratio of calcein to 
ethidium homodimer-1 intensity (P=0.0058 and P=0.0009, 
respectively compared to the cells treated with medium, 
mean ± SD of n=4–7 images of 0.04 mm2 from a representa-
tive experiment, Figure 2B and C). 
Treatment of subcultured RPE cells with AV-17 yielded 
similar results as the primary cells. The 5-minute exposure 
to the solvent or 0.125 mg/mL AV-17 was well tolerated, 
whereas the cells treated with 0.25 and 0.5 mg/mL AV-17 
exhibited gradually lower levels of calcein with a slight, 
dose-dependent increase in ethidium homodimer-1 uptake. 
The viability score was reduced by 43% in the subcultured 
RPE cells treated with 0.5 mg/mL AV-17 (P=0.0075 com-
pared to the cells treated with medium, mean ± SEM of n=3 
independent experiments, Figure 2D).
To determine the extent of apoptosis, we performed 
immunostainings for cleaved CASP3 on the primary and 
subcultured RPE cells. The former group of cells treated with 
the solvent or 0.125 mg/mL AV-17 exhibited a very weak 
staining after both the 30-second and 5-minute exposures. 
However, a significant increase by ~25% was observed in 
the levels of cleaved CASP3 in the cells exposed to 0.25 and 
0.5 mg/mL AV-17 for 5 minutes (P=0.0032 and P=0.0381, 
respectively, mean ± SD of n=6–7 images of 0.04 mm2). In 
the subcultured RPE cells, a significant increase in cleaved 
CASP3 intensity was detected only in the groups treated 
with 0.5 mg/mL AV-17 for 5 minutes (P0.0001 compared 
to the cells treated with medium, mean ± SD of n=10 images 
of 0.04 mm2, Figure 3). 
We also analyzed viability by performing MTT test on 
the subcultured and differentiated RPE cells. Interestingly, 
the 30-second exposure resulted in a slight but insignificant 
decrease of ~18% in the absorbance values in response to 
0.125 and 0.25 mg/mL AV-17 (P=0.1322 and P=0.0769, 
respectively; mean ± SEM of n=3 independent experi-
ments). A significant reduction of 28% was observed in the 
absorbance values of cells treated with 0.05 mg/mL AV-17 
(P=0.0416; mean ± SEM of n=3 independent experiments). 
Exposure to 0.0625 mg/mL AV-17 or the solvent alone did 
not result in a significant difference compared to the medium-
treated cells (Figure 4). 
Organization of the actin cytoskeleton 
after exposure to aV-17
The control group of primary RPE cells treated with 
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with circumferential actin filaments. In contrast, the 
dedifferentiated control cells incubated with 10 ng/mL 
TGFbeta-2 exhibited a morphology dominated by fibroblasts 
and abundant stress fibers. The 30-second exposure to the 
solvent or dye did not result in a remarkable difference in 
cellular morphology or the organization of the actin cytoskel-
eton that would suggest dedifferentiation. After the 5-minute 
exposure, the polygonal morphology and the circumferen-
tially arranged actin filaments were maintained in the cells 
treated with the solvent and 0.125 mg/mL AV-17. However, 
with increasing concentrations of the dye, the actin filaments 
became less restricted to the cell–cell borders (Figure 5). 
extent of differentiation in the rPe 
cells after exposure to aV-17
The integrity of the tight and adherens junctions was exam-
ined by performing immunostainings for ZO-1 and CTNNB1, 
respectively. After the 5-minute exposure to the solvent or 
0.125 mg/mL AV-17, expression of both proteins at the 
cellular junctions was well preserved in the primary RPE 
cells. However, the incubation with 0.25 and 0.5 mg/mL 
AV-17 resulted in an ~15%–25% decrease in the ratio of 
junctional to cytoplasmic ZO-1 (P0.0001, mean ± SEM 
of n=6–12 images) and a 14.5% increase in cytoplasmic 
CTNNB1, respectively (P=0.0001, mean ± SEM of n=11–18 
images of 0.04 mm2, Figure 6).
Likewise, in the subcultured RPE cells treated with the 
solvent or 0.125 mg/mL AV-17 for 5 minutes, CTNNB1 
was primarily localized to the cell–cell junctions with very 
little cytoplasmic or nuclear staining. However, exposure to 
0.25 and 0.5 mg/mL AV-17 resulted in a significant decrease 
of 25%–33% in the ratios of junctional to cytoplasmic 
CTNNB1, respectively (P0.0001, mean ± SD of n=9–12 
images of 0.04 mm2, Figure 7A and B).
In the differentiated primary RPE cells, we did not detect 
any immunoreactivity for the intermediate filament KRT19 
Figure 2 Live/dead assay demonstrating the time and dose-dependent viability of RPE cells after exposure to AV-17.
Notes: Primary RPE cells exposed to the solvent or 0.125 mg/mL AV-17 for (A) 30 seconds and (B) 5 minutes exhibited a high degree of viability, demonstrated by the 
strong levels of calcein staining and very low levels of ethidium homodimer-1 (EH) uptake, similar to the control group treated with culture medium. In contrast, a decrease 
in calcein intensity and increase in EH uptake were detected after exposure to higher concentrations. Cells incubated in 600 µM h2O2 were included as positive controls 
for eh staining. The nuclei were counterstained with DaPi. scale bar =25 µm. (C) Viability score of the primary rPe cells after exposure to aV-17 or solvent for 5 minutes, 
calculated from the ratio of the intensity of calcein staining to the intensity of EH uptake. Quantification was performed in n=4–7 images of 0.04 mm2 of a representative 
set of experiments, with a minimum of n=32 cells per group. The experiments were repeated three times. P-values were compared to the control group treated in culture 
medium. (D) subcultured rPe cells exhibited a similar response to the primary rPe cells after exposure to the solvent or aV-17 at the tested concentrations for 5 minutes, 
as demonstrated by the viability scores (mean ± seM of n=3 independent experiments, with a minimum of n=68 cells quantified per group). P-values were compared to the 
control group in culture medium.
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Biocompatibility of aV-17 on rPe cells
Figure 3 extent of CasP3 cleavage demonstrating the time and dose-dependent apoptotic activity after exposure to aV-17. 
Notes: a very low level of CasP3 cleavage was detected in the subcultured rPe cells exposed to the solvent or lower concentrations of aV-17 for (A) 30 seconds and 
(B) 5 minutes, similar to the control group treated with culture medium. However, the exposure to 0.5 mg/mL resulted in an increase in the levels of cleaved CASP3 
immunostaining, which became more prominent after 5-minute exposure. Cells incubated in 600 µM h2O2 were included as positive controls for the immunostaining. Cells 
incubated in the blocking buffer alone without the primary antibody served as negative controls. The nuclei were counterstained with DAPI. Scale bar =25 µm. (C) intensity 
of the cleaved CASP3 immunostaining after the treatment of primary RPE cells for 5 minutes. Quantification was performed in n=6–10 images of 0.04 mm2 of a representative 
set of experiments, with a minimum of n=79 cells per group. The experiments were repeated three times. P-values were compared to the control group treated in culture 
medium. (D) Intensity of the cleaved CASP3 immunostaining after treating the subcultured RPE cells for 5 minutes. Quantification was performed in n=8–16 images of 
0.04 mm2 of a representative set of experiments, with a minimum of n=57 cells per group. The experiments were repeated three times. P-values were compared to the 
control group treated in culture medium.
Abbreviations: RPE, retinal pigment epithelial; DAPI, 4′,6-diamidino-2-phenylindole; AV-17, Acid Violet-17.
Figure 4 MTT assay demonstrating the extent of rPe viability in terms of metabolic activity. 
Notes: Subcultured and differentiated RPE cells exposed to the solvent or 0.0625 mg/mL AV-17 for 30 seconds exhibited a similar degree of viability as the cells treated 
with medium. However, a gradual decrease was observed in the absorbance values after exposure to increasing concentrations of AV-17, which became significant at 
0.5 mg/mL AV-17 (P-value compared to the cells treated with medium). a group of cells were left untreated to ensure that the removal of the medium and the subsequent 
washing steps did not result in cell loss. Data represent the mean ± seM of n=3 independent experiments.
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Figure 5 Organization of the actin cytoskeleton in primary RPE cells determined by Alexa 488-phalloidin staining. 
Notes: Cells (12 weeks of differentiation) exposed to the solvent or 0.125 mg/mL AV-17 for (A) 30 seconds and (B) 5 minutes exhibited a polygonal morphology, with the 
actin filaments organized mainly as circumferential bundles underneath the plasma membrane, similar to the differentiated cells in the control group treated with medium 
only. However, the 5-minute exposure to 0.25 and 0.5 mg/mL AV-17 resulted in the slight reorganization of the actin cytoskeleton, with the formation of some stress fibers 
in the cytoplasm. A group of cells incubated with 10 ng/mL TGFbeta-2 were included as controls for the dedifferentiated cells. Scale bar =25 µm.
Abbreviations: RPE, retinal pigment epithelial; AV-17, Acid Violet-17; DAPI, 4′,6-diamidino-2-phenylindole.
Figure 6 integrity of the tight and adherens junctions in the primary rPe cells after exposure to aV-17. 
Notes: Exposure of cells (12 weeks of differentiation) to 0.5 mg/mL AV-17 for 5 minutes compromised the integrity of both the tight (A) and adherens junctions 
(B), as determined by the ZO-1 and CTnnB1 immunostainings, respectively. These structures and the hexagonal morphology were well preserved in the cells exposed 
to 0.125 mg/mL AV-17 or the solvent. Scale bar =25 µm. (C) Quantification of the integrity of tight junctions, as determined from the ratio of the ZO-1 immunostaining 
at the cell–cell boundaries to the intensity of the cytoplasmic ZO-1 staining. Quantification was performed in n=6–15 images of 0.04 mm2 of a representative set of 
experiments, with a minimum of n=44 cells per group. The experiments were repeated three times. P-values were compared to the control group treated in culture medium. 
(D) Quantification of the cytoplasmic CTNNB1 immunostaining in n=11–18 images of 0.04 mm2 of a representative set of experiments, with a minimum of n=107 cells per 
group. The experiments were repeated three times. P-values were compared to the control group treated in culture medium.
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Biocompatibility of aV-17 on rPe cells
in any of the treatment groups (data not shown). KRT19 was 
also expressed at very low levels in the subcultured RPE cells 
treated with the normal medium, solvent or 0.125 mg/mL 
AV-17 for 5 minutes. However, the cells exposed to 0.25 
and 0.5 mg/mL of AV-17 exhibited a gradual and significant 
increase in KRT19 expression by 35% and 56%, respectively 
(P=0.0095 and P=0.0071, respectively; mean ± SEM of n=3 
independent experiments, Figure 7A and C).
Discussion
In this study, we evaluated the viability and differentiation 
of bovine RPE cells after exposure to the vital dye AV-17. 
Cultures of bovine RPE cells were preferred since these cells 
can be isolated from post-mortem eyes with a high yield and 
differentiated in vitro. Bovine RPE cells therefore provide an 
easily available and cost-effective alternative, which does not 
entail ethical issues, unlike the establishment of human RPE 
cultures. The differentiated bovine cells are also expected to 
simulate the in vivo conditions better than the transformed 
human RPE cell line ARPE-19, which was found to be rela-
tively robust to different treatments.21
To enable differentiation, we initially allowed the bovine 
RPE cells to reach confluence for the formation of cellular 
junctions. Afterward, serum concentration was gradually 
lowered from 10% to 2% to prevent the overgrowth of cells.26 
These conditions induced the differentiation of both the 
Figure 7 expression of CTnnB1 and KrT19 in the subcultured rPe cells. 
Notes: (A) Exposure of cells (passage 4, 12 weeks in low-serum medium) to 0.25 and 0.5 mg/mL AV-17 for 5 minutes compromised the integrity of the adherens junctions, 
as detected by the increase in the cytoplasmic and nuclear expression of CTnnB1. in contrast, CTnnB1 was mainly localized underneath the plasma membrane in the cells 
exposed to 0.125 mg/mL AV-17 or the solvent, similar to the control cells treated with medium. Likewise, the expression of KRT19 underwent a gradual and dose-dependent 
increase in the cells exposed to 0.25 and 0.5 mg/mL AV-17 for 5 minutes. Scale bars =25 µm. (B) Quantification of the integrity of the adherens junctions, as determined from 
the ratio of the CTNNB1 immunostaining at the cell–cell boundaries to the intensity of the cytoplasmic CTNNB1 staining. Quantification was performed in n=9–18 images 
of 0.04 mm2 of a representative set of experiments, with a minimum of n=48 cells per group. The experiments were repeated three times. P-values were compared to the 
control group treated in culture medium. (C) Quantification of the KRT19 expression in cytoplasm. Data represent the mean ± seM of n=3 independent experiments, with 
the quantification of a minimum of n=116 cells per group. P-values were compared to the control group treated in culture medium.
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primary and the subcultured RPE cells satisfactorily in our 
study. Both cell types exhibited a similar degree of sensitivity 
to AV-17 as evaluated by the live/dead assay. The subcultured 
bovine RPE cells can therefore serve as a flexible alterna-
tive to primary RPE cells for viability studies. However, 
the extent of differentiation was more compromised in the 
subcultured RPE cells after dye treatment, as determined by 
the upregulation of KRT19. Expression of the tight junction 
protein ZO-1 also remained weak in most of the subcultured 
RPE cells (data not shown), suggesting that the establishment 
of tight junctions requires a longer period after cell detach-
ment and reattachment, possibly due to the loss of junctional 
components from the membrane after protease treatment. For 
evaluating the differentiation state of RPE cells in response 
to dye exposure, we therefore recommend the use of primary 
RPE cells to simulate the normal in vivo conditions. However, 
the subcultured RPE cells may also provide valuable informa-
tion on the response of already slightly compromised RPE 
cells in a pathological environment.
In this study, RPE cells were incubated for 30 seconds 
and 5 minutes with different concentrations of the dye. These 
time periods were selected to simulate the surgical conditions 
during which the dye is applied. Our results demonstrated that 
the exposure to 0.125 mg/mL AV-17 or solvent for 30 seconds 
and 5 minutes did not result in any signs of toxicity as deter-
mined by the live/dead assay and CASP3 cleavage. However, 
the MTT assay demonstrated a slight decrease of ~18% in 
mitochondrial activity after a 30-second exposure to 0.125 
and 0.25 mg/mL AV-17. This decrease became significant 
with 0.5 mg/mL of the dye, whereas only the exposure to 
0.0625 mg/mL AV-17 or solvent appeared to be well tolerated 
according to the MTT assay. Our findings were consistent 
with the results of a former study on ARPE-19 cells, which 
demonstrated a significant decrease of ~25% in the absor-
bance values determined by the MTT test after 3-minute 
exposure to 0.25 and 0.5 mg/mL AV-17. Likewise, the dye 
at the concentrations of 0.05 and 0.005 mg/mL were well 
tolerated, with a reduction of 5% in the absorbance values.13 
Interestingly, other groups evaluating the biocompatibility of 
vital dyes also reported more damage with the MTT assay 
than was seen with light and electron microscopy, suggest-
ing that the dyes may have a greater effect on mitochondrial 
function.27–29 However, the remnants of the dye could also 
have interfered with the MTT assay, resulting in a dose-
dependent reduction in the absorbance values.
We have previously demonstrated that the 5-minute 
exposure to 0.125 mg/mL AV-17 or the solvent was well 
tolerated in bovine retinal cells.8 Here, we report that the 
exposure to AV-17 at higher concentrations not only reduces 
viability but also triggers the dedifferentiation of RPE cells 
by compromising the integrity of cellular junctions and the 
organization of actin cytoskeleton. Our findings are also 
mainly in accordance with the results of a previous study on 
the retinal biocompatibility of AV-17, which was reported 
to be superior to TB and ICG. However, contrary to our 
findings, good biocompatibility was stated even for the con-
centration of 0.5 mg/mL.7 In the former study, the dye was 
applied into the vitreous humor. The discrepancy between 
the results might therefore have resulted from the protective 
effects of the vitreous humor, which was described in detail 
for the drug triamcinolone.30–32
AV-17 belongs to the same group of substances, the trityl 
dyes, such as BBG and PB. Therefore, the staining of ILM 
at the suggested concentrations could be applicable. A recent 
study demonstrated that 3-minute exposure of vitrectomized 
cadaveric eyes to 0.05 mg/mL of AV-17 enabled the distinction 
of ILM from the underlying retina with a high degree of con-
trast and facilitated the surgical peeling of ILM.13 The efficacy 
of AV-17 to stain ILM at this low concentration together with 
our findings therefore underline the potential of AV-17 as a 
novel alternative for vital dyes in vitreoretinal surgery. 
Conclusion
The application of AV-17 at a concentration under 0.125 mg/mL 
in a D
2
O-carrying solvent appears safe for intraocular admin-
istration and RPE changes or atrophy are unlikely to occur in 
case AV-17 migrates into the subretinal space. Nevertheless, 
similar to the intraocular application of BBG, restricting the 
time the retina is exposed to this dye would be recommended 
to avoid adverse effects. The in vivo staining characteristics 
and acceptance of a new formulation of AV-17/D
2
O in clinical 
practice also need to be established.
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